Olanzepine
Chemical
Thienobenzodiazepine → 2nd gen antipsychotic (ATYPICAL)
Use
- Schizophrenia
- Bipolar
- Resistant depression
- Delirium in ICU
Presentation
Tablets
Depot injection
Vial → 10mg for reconstitution
Dose
5 – 10mg/day
Route
PO/IM/IV
Onset
PO 5hrs
IM 15mins
MoA (mechanism)
- Unknown
- Dopamine & serotonin antagonism
- Also antagonises α1, M1 – 5 & H1 receptors (side effects)
PD
CNS – relieves +ve & -ve symptoms of schizophrenia
PK
A
60% OBA
Extensive 1st pass
D
VD 1L
93% PPB
M
CYP450
Glucuronidation & oxidation
E
Metabolites in urine
t ½ B 20 – 60hrs
Adverse Effects
- Hypotension
- Weight gain
- Fatigue
- Dry mouth
- Akathisia
Drug interactions: CYP1A2 inducers (alcohol, carbamazepine) = ↑clearance
Classical & Atypical Antipsychotics
Classic
D2 receptor blockade
Extrapyramidal S/E
2° strong D2 block
Effective for +ve symptoms
Atypical
Serotonin, D4 & D2 (weak)
Receptor blockade
Weak D2 blockade ∴ less incidence of EPSE
Effective for +ve & -ve symptoms